Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease (APM-Project)

F

Florian Lordick, MD

Status

Unknown

Conditions

Cancer Disease, Palliative Therapy

Treatments

Other: validated questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT02751723
DRKS00007536 (Registry Identifier)
APM Project

Details and patient eligibility

About

The aim of this non-investigational study is to determine the symptoms and disease burden at the time point of diagnosis and in the further course of an incurable cancer disease. The needs and preferences of patients suffering from cancer (ovarian carcinoma, breast cancer, malignant melanoma, lung cancer, stomach cancer, oesophageal cancer, pancreatic cancer, cancer of the hepatobiliary system, colorectal cancer, head and neck cancer) are examined by various validated questionnaires. The data obtained by these questionnaires are collected together with information obtained by the treating physicians at four time points during the study: t0 - patient´s enrollment, at the moment of diagnosis and before the start of tumor therapy, respectively; T1 - 3 months after patient´s enrollment; T2 - 6 months after patient´s enrollment; T3 - 12 months after patient´s enrollment. This highly innovative project offers the chance to identify medical services deficits and risk circumstances for the burden of treatments in an oncology-palliative setting and to optimize the quality of patient care.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Incurable cancer disease: ovarian carcinoma, breast cancer, malignant melanoma, lung cancer, stomach cancer, oesophageal cancer, pancreatic cancer, cancer of the hepatobiliary system, colorectal cancer, head and neck cancer
  • signed and dated Inform Consent Form
  • Age ≥ 18 years

Exclusion criteria

  • Patient is not able to understand and to answer questions
  • Patient is in a critical health situation and is directly threatened due to cancer disease or the resulting complications

Trial design

500 participants in 10 patient groups

lung cancer
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
malignant melanoma
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
cancer of the hepatobiliary system
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
head and neck cancer
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
breast cancer
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
ovarian carcinoma
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
pancreatic cancer
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
stomach cancer
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
oesophageal cancer
Description:
validated questionnaires
Treatment:
Other: validated questionnaires
colorectal cancer
Description:
validated questionnaires
Treatment:
Other: validated questionnaires

Trial contacts and locations

21

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems